In vitro susceptibility of Paracoccidioides brasiliensis yeast form to antifungal agents.
D000666:Amphotericin B / Q000494:pharmacology*; D003596:Cytosine / Q000031:analogs & derivatives*; D004338:Drug Combinations; D004347:Drug Interactions; D004357:Drug Synergism; D005437:Flucytosine / Q000494:pharmacology*; D005658:Fungi / Q000187:drug effects*; D066298:In Vitro Techniques; D007654:Ketoconazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010228:Paracoccidioides / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology*
D004338:Drug Combinations; D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine; D007654:Ketoconazole; D012293:Rifampin